Treatment of Ocular Neurodegenerative Diseases: An In-Depth Comparison of Anc80 and AAV9 Including Cross-Reactivity of Pre-Existing Antibodies in Human Serum

被引：0
|
作者：
Schwartz, Maura [1 ,2 ]
Howard, Abigail [1 ]
Baird, Megan [1 ,2 ]
Likhite, Shibi [1 ]
Meyer, Kathrin [2 ]
机构：
[1] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Columbus, OH USA
[2] Ohio State Univ, Columbus, OH 43210 USA
来源：
MOLECULAR THERAPY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
305
引用
收藏
页码：147 / 147
页数：1
相关论文
共 2 条
  • [1] In-depth comparison of Anc80L65 and AAV9 retinal targeting and characterization of cross-reactivity to multiple AAV serotypes in humans
    Schwartz, Maura K.
    Likhite, Shibi
    Vetter, Tatyana A.
    Baird, Megan C.
    Mcgovern, Vicki
    Delgado, Andrea Sierra
    Mendel, Tom
    Burghes, Arthur
    Meyer, Kathrin C.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2023, 30 : 16 - 29
  • [2] Xork-Fc, an Engineered IgG Protease, Shows Low Cross-Reactivity to Pre-Existing Antibodies in Human Serum and Enables Efficient AAV Transduction in an In Vivo Model of Passive Transfer of Neutralizing Human Serum
    Li, Ning
    Michaud, Alicia M.
    Capela, Teresa
    Yu, Houqing
    Ge, Jingping
    Swami, Pooja
    Nordgren, Maria
    Lood, Rolf
    Leung, Sheldon S.
    Ilyinskii, Petr O.
    Kishimoto, Kei
    MOLECULAR THERAPY, 2023, 31 (04) : 364 - 364
1